Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance For General Drug Use To Assess The Safety And Efficacy Profile Of Viviant In Usual Practice.

NCT01793142 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01793142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance For General Drug Use To Assess The Safety And Efficacy Profile Of Viviant In Usual Practice.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 24, 2013
Completion date
May 31, 2017
Enrollment
3,430 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis